Results 101 to 110 of about 224,706 (187)

Graves’ orbitopathy: the importance of statin therapy [PDF]

Background. Graves’ orbitopathy is the most common extrathyroidal autoimmune disorder, predominantly caused by hyperthyroidism. Prevention and development of an individualized treatment plan involve the use of statins and the management of risk factors:
Rizov, Cristina, Tidvă, Adelina
core  

Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?

Clinical Case Reports, 2018
Key Clinical Message A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell
Luminita Nicoleta Cima, Ioana Maria Lambrescu, Lavinia Stejereanu, Anca Colita, Reuven Or, Simona Fica   +5 more
doaj   +1 more source

Diagnostic Approaches to and Disaese Course Modifying Therapies in Graves Orbitopathy

Graves' Orbitopathy (GO) is an autoimmune condition that primarily affects the orbit, causing inflammation, muscle expansion, and tissue changes. Although often linked to Graves' Disease (GD), 5-10% of GO patients may not have GD at diagnosis.
Muthomi, Brenda Shey Wanjira
core  

Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.

, 2009
Aim: To compare the outcome of various surgical approaches of orbital decompression in patients with Graves' orbitopathy (GO) receiving surgery for disfiguring proptosis.
MARINO', MICHELE, Currò N, Freidel M, Bijl H, PINCHERA, ALDO, Salvi M, Mourits MP, Mohr Ch, Neoh C, Nardi M, Pinchera A, Kahaly GJ, Sellari Franceschini S, Pitz S, Altea MA, NARDI, MARCO, Guastella C, Orgiazzi J, European Group on Graves' Orbitopathy, von Arx G, Marcocci C, MARCOCCI, CLAUDIO, Boboridis K, Wiersinga WM, Eckstein A, Lane CM, Wiersinga W.M., Stahl M, BALDESCHI, LELIO, Saeed P, SELLARI FRANCESCHINI, STEFANO, Lareida J, Kalmann R, Krassas GE, Curr? N, Dickinson AJ   +35 more
core   +1 more source

What\u27s New in Graves\u27 Orbitopathy?

, 2018
Graves\u27 orbitopathy (GO) is the most frequent extrathyroidal manifestation of Graves\u27 disease (GD). Depending upon the diagnostic criteria used up to 50% of patients with GD have ophthalmic findings; with lid retraction/lid lag being the most ...
Jim Garrity, MD
core   +1 more source

Targeted immunotherapies for Graves’ thyroidal & orbital diseases

Frontiers in Immunology
BackgroundGraves’ hyperthyroidism and its associated Graves’ orbitopathy are common autoimmune disorders associated with significant adverse health impact.
Alan Chun Hong Lee, George J. Kahaly
doaj   +1 more source

Subclinical optic neuropathy in Graves' orbitopathy

, 2003
Purpose: The aims of the study were to detect early changes in the optic nerve function of patients with Graves' orbitopathy (GrO) who do not have any signs and symptoms of optic neuropathy, using pattern visual evoked potentials (P-VEP), and investigate
Simsek, TÜLAY, Acaroglu, G, Ozalp, S, Mutluay, A   +3 more
core   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

Association between lipid profiles and Graves orbitopathy: A systematic review and meta analysis

Endocrine and Metabolic Science
Introduction: Graves orbitopathy (GO) is an autoimmune disorder affecting the tissues around the eyes, seen in 25–50 % of individuals with Graves disease (GD).
Nanny Natalia Mulyani Soetedjo, Louis Fabio Jonathan Jusni, Eric Ricardo Yonatan, Steven Alvianto, Nicolas Daniel Widjanarko, Hikmat Permana   +5 more
doaj   +1 more source

Treatment of Graves' Orbitopathy in 1990.

The Keio Journal of Medicine, 1991
In a mechanical sense, we understand how the orbital changes and the symptoms of endocrine ophthalmopathy develop. Expansion of the retrobulbar tissues results in forward displacement of the globe beyond the protective cover of the eyelids. Lymphocytic infiltration, followed by fibrosis of the extraocular muscles and the eyelid retractors, leads to ...
openaire   +3 more sources